Abstract:Objective: To analyse the efficacy of recombinant human growth hormone (rhGH) treatment in children born small for gestational age (SGA) with syndormic and non-syndormic short stature. Methods: The clinical data of 59 children born SGA who were diagnosed as short stature and admitted to the Center of Endocrinology, Genetics and Metabolism, Beijing Children's Hospital from July 2012 to June 2021 were collected and analyzed. According to the 2019 consensus on short stature, they were divided into syndromic group and non-syndromic group. Before treatment and 6, 12, 18 and 24 months after treatment, height standard deviation score (Ht-SDS), difference of height standard deviation (∆Ht-SDS) and homeostasis model assessment-insulin resistance index (HOMA-IR) were compared between groups, while Ht-SDS and HOMA-IR were compared before and after treatment. Independent t test or Kruskal-Wallis test were used for comparison between the 2 groups, and paired t test or Mann-Whitney U test were used for the intra-group comparison. Results: Among the 59 cases, 37 were males and 22 females, aged (5.5±2.3) years. There was no significant difference in Ht-SDS after 12 months of treatment between 2 groups (0.9±0.4 vs. 1.2±0.4, t=1.68, P=0.104) or in height SDS after 24 months of treatment (1.4±0.7 vs. 1.9±0.5, t=1.52, P=0.151). After 12 months of treatment, the insulin resistance index of the non-syndromic group was significantly higher than that of the syndromic group (2.29 (1.43, 2.99) vs. 0.90 (0.55, 1.40), Z=-2.95, P=0.003). There were significant differences in Ht-SDS between 6 months and before treatment, 12 months and 6 months in syndromic type (Z=7.65, 2.83 P<0.001, P=0.020), but all were significant differences in non-syndromic type between 6 months and before treatment, 12 months and 6 months, 18 months and 12 months, 24 months and 18 months (Z=11.95, 7.54, 4.26, 3.83, all P<0.001). Conclusion: The efficacy of rhGH treatment in children born SGA is comparable between syndromic and non-syndromic short stature cases, but non-syndromic children treated with rhGH need more frequent follow-up due to the risk of insulin resistance.

Analysis on the psychological status of children with single nucleotide polymorphisms related idiopathic short stature in exon 10 of growth hormone receptor gene

Long-Term Efficacy and Safety of Recombinant Human Growth Hormone in Children Born Small for Gestational Age.

Associations of Single Nucleotide Polymorphisms of Growth Hormone Receptor with Susceptibility to Idiopathic Short Stature

Progress of Association Between Gene Mutations, Polymorphisms of Growth Hormone Receptor and Idiopathic Short Stature

Comparison of Genotype Distribution of Growth Hormone Receptor Exon 3 Deletion Polymorphism between Children with and without Short Stature

Genetic studies of 77 cases of short stature with unknown etiology

[Relationship Between the Polymorphism of Growth Hormone Receptor Ex3 and the Efficacy of Rhgh Treatment in Children with Idiopathic Short Stature].

Clinical profiles and molecular genetic analyses of 98 Chinese children with short statures

Association of Change on Insulin-Like Growth Factor (Igf)-I and IGF-binding Protein 3 with Genetic Markers after a Month of Growth Hormone (GH) Therapy on Chinese Children Born with GH Deficiency

Identification of 11 Potentially Relevant Gene Mutations Involved in Growth Retardation, Intellectual Disability, Joint Contracture, and Hepatopathy

Etiologic and remedial study of 1038 children with short stature

ASSOCIATION ANALYSIS OF POLYMORPHISMS IN SIX GENES WITHIN THE GH/IGF-1 AXIS IN PATIENTS WITH IDIOPATHIC SHORT STATURE IN THE CHINESE HAN POPULATION

Efficacy of Recombinant Human Growth Hormone Treatment in Children Born Small for Gestational Age with Syndromic and Non-Syndromic Short Stature

Etiologic and Related Analysis of 164 Children with Short Stature in Suzhou Area

Polymorphisms of the Ghrelin/Obestatin Gene and Ghrelin Levels in Chinese Children with Short Stature

Association Between Polymorphisms of IGF-1R Gene and Idiopathic Short Stature in Jiangxi Province

Molecular Genetic Analysis and Growth Hormone Treatment in a Three-Generation Chinese Family with Tricho-Rhino-Phalangeal Syndrome I

Research of IGF-1R Gene Polymorphisms in Boys with Idiopathic Short Stature

Disorder of the Growth Hormone/insulin-Like Growth Factors Axis in Children with Idiopathic Short Stature

Genetic Evaluation of 114 Chinese Short Stature Children in the Next Generation Era: a Single Center Study.

Efficacy and safety of recombinant human growth hormone in treating Chinese children with idiopathic short stature